
Researchers at UC Berkeley have identified a compound that could transform weight-loss treatment by helping the body burn more energy instead of suppressing appetite like Ozempic and Wegovy. In mice, the compound boosted energy expenditure by up to 18%, improved blood sugar control, reduced liver fat, and promoted weight loss without significant muscle loss. Even more promising, combining it with existing GLP-1 medications produced greater benefits than either treatment alone….


